Impact of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) on Cardiovascular Outcomes in Heart Failure With Reduced Ejection Fraction Under Contemporary Standard Care: A Systematic Review and Meta-Analysis. Here, SLC5A2 is linked to heart failure.